Literature DB >> 31675482

DAMPs, PAMPs, and LAMPs in Immunity and Sterile Inflammation.

Joel Zindel1,2,3,4, Paul Kubes1,2,5.   

Abstract

Recognizing the importance of leukocyte trafficking in inflammation led to some therapeutic breakthroughs. However, many inflammatory pathologies remain without specific therapy. This review discusses leukocytes in the context of sterile inflammation, a process caused by sterile (non-microbial) molecules, comprising damage-associated molecular patterns (DAMPs). DAMPs bind specific receptors to activate inflammation and start a highly optimized sequence of immune cell recruitment of neutrophils and monocytes to initiate effective tissue repair. When DAMPs are cleared, the recruited leukocytes change from a proinflammatory to a reparative program, a switch that is locally supervised by invariant natural killer T cells. In addition, neutrophils exit the inflammatory site and reverse transmigrate back to the bloodstream. Inflammation persists when the program switch or reverse transmigration fails, or when the coordinated leukocyte effort cannot clear the immunostimulatory molecules. The latter causes inappropriate leukocyte activation, a driver of many pathologies associated with poor lifestyle choices. We discuss lifestyle-associated inflammatory diseases and their corresponding immunostimulatory lifestyle-associated molecular patterns (LAMPs) and distinguish them from DAMPs.

Entities:  

Keywords:  DAMP; damage-associated molecular pattern; inflammation; leukocyte migration; leukocyte trafficking; reverse leukocyte migration; sterile injury

Mesh:

Substances:

Year:  2019        PMID: 31675482     DOI: 10.1146/annurev-pathmechdis-012419-032847

Source DB:  PubMed          Journal:  Annu Rev Pathol        ISSN: 1553-4006            Impact factor:   23.472


  114 in total

1.  Characterization of neutrophil-neuronal co-cultures to investigate mechanisms of post-ischemic immune-mediated neurotoxicity.

Authors:  Nguyen Mai; Viollandi Prifti; Minsoo Kim; Marc W Halterman
Journal:  J Neurosci Methods       Date:  2020-05-20       Impact factor: 2.390

Review 2.  New aspects of hepatic endothelial cells in physiology and nonalcoholic fatty liver disease.

Authors:  Xinghui Sun; Edward N Harris
Journal:  Am J Physiol Cell Physiol       Date:  2020-05-06       Impact factor: 4.249

Review 3.  Toll-like receptors and damage-associated molecular patterns in the pathogenesis of heart transplant rejection.

Authors:  Alice Kesler; Devendra K Agrawal; Finosh G Thankam
Journal:  Mol Cell Biochem       Date:  2022-06-09       Impact factor: 3.396

Review 4.  Neuroinflammation after surgery: from mechanisms to therapeutic targets.

Authors:  Ting Yang; Ravikanth Velagapudi; Niccolò Terrando
Journal:  Nat Immunol       Date:  2020-10-19       Impact factor: 25.606

Review 5.  Targeting immune cell metabolism in kidney diseases.

Authors:  Paulo José Basso; Vinicius Andrade-Oliveira; Niels Olsen Saraiva Câmara
Journal:  Nat Rev Nephrol       Date:  2021-04-07       Impact factor: 28.314

Review 6.  The role of immune-mediated alterations and disorders in ALS disease.

Authors:  João Rodrigues Lima-Junior; David Sulzer; Cecilia S Lindestam Arlehamn; Alessandro Sette
Journal:  Hum Immunol       Date:  2021-02-12       Impact factor: 2.850

Review 7.  Immunological mechanisms underlying sterile inflammation in the pathogenesis of atherosclerosis: potential sites for intervention.

Authors:  Roland Truong; Finosh G Thankam; Devendra K Agrawal
Journal:  Expert Rev Clin Immunol       Date:  2020-12-21       Impact factor: 4.473

Review 8.  Biomaterials-Driven Sterile Inflammation.

Authors:  Henry Chen; Devendra K Agrawal; Finosh G Thankam
Journal:  Tissue Eng Part B Rev       Date:  2021-02-23       Impact factor: 6.389

9.  RAGE impairs murine diabetic atherosclerosis regression and implicates IRF7 in macrophage inflammation and cholesterol metabolism.

Authors:  Laura Senatus; Raquel López-Díez; Lander Egaña-Gorroño; Jianhua Liu; Jiyuan Hu; Gurdip Daffu; Qing Li; Karishma Rahman; Yuliya Vengrenyuk; Tessa J Barrett; M Zahidunnabi Dewan; Liang Guo; Daniela Fuller; Aloke V Finn; Renu Virmani; Huilin Li; Richard A Friedman; Edward A Fisher; Ravichandran Ramasamy; Ann Marie Schmidt
Journal:  JCI Insight       Date:  2020-07-09

10.  P2Y2 receptor antagonism resolves sialadenitis and improves salivary flow in a Sjögren's syndrome mouse model.

Authors:  Kimberly J Jasmer; Lucas T Woods; Kevin Muñoz Forti; Adam L Martin; Jean M Camden; Marco Colonna; Gary A Weisman
Journal:  Arch Oral Biol       Date:  2021-02-03       Impact factor: 2.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.